Founded Year

2014

Stage

IPO | IPO

Total Raised

$32.64M

Date of IPO

12/11/2019

About JLK Group

JLK Group develops an AI-based medical diagnosis support system. The company focuses on applying image-processing and artificial intelligence technology to provide medical management, efficient medical treatment, and transparent medical service not only in brain diseases such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease but also in lung diseases, coronary artery disease, prostate cancer, and digital pathology.

JLK Group Headquarters Location

#302, Mirae YunghamGisul B/D 40, Yeongudanji-ro, Ochang-eup, Cheongwon-gu

Cheongju-si, 28116,

South Korea

+82 70 4651 4051

JLK Group's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

JLK Group's Products & Differentiation

See JLK Group's products and how their products differentiate from alternatives and competitors

  • ATROSCAN

    MEDIHUB DEMENTIA visualizes brain images in 2D and 3D and provides cortical thickness analysis results of functionally and structurally segmented brain regions. History of a patient’s record is available within the diagnosis report. (Multilingual support)

    Differentiation

    visualizes brain images in 2D and 3D images and structurally segments brain area in 72 parts 

    Provides functions for tracking analysis/management 

    Numerous analysis data and quantitative comparison analysis function 

    Provides personalized reports on analysis results 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing JLK Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

JLK Group is included in 6 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,452 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

10,181 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

JLK Group Patents

JLK Group has filed 5 patents.

The 3 most popular patent topics include:

  • Artificial intelligence
  • Artificial neural networks
  • Machine learning
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/14/2017

3/23/2021

Artificial neural networks, Stroke, Machine learning, Artificial intelligence, Rare diseases

Grant

Application Date

9/14/2017

Grant Date

3/23/2021

Title

Related Topics

Artificial neural networks, Stroke, Machine learning, Artificial intelligence, Rare diseases

Status

Grant

Latest JLK Group News

STARTUP FOCUS: JLK eyes global expansion with AI-based medical diagnosis solution2021.10.19 15:41

Oct 19, 2021

STARTUP FOCUS: JLK eyes global expansion with AI-based medical diagnosis solution 2021.10.19 15:41:56 | 2021.10.19 15:43:16 Receiver JLK Inspection`s Chief Executive Kim Dong-min [Source: JLK Inspection] JLK Inspection, the first AI-enabled medical solution company to go public on the Kosdaq, expects to expand in the global market with its AI-based Medical Genomics technology capable of simultaneous reading of medical imaging and human genome without security threat. The Seoul, South Korea-based medical solutions provider is well known for its diagnosis platform named AIHuB developed to quickly detect cancer and lung diseases based on a solution that precisely analyzes eight types of medical images from MRI, CT, and X-Ray, among others. AIHub equipped with integrated AI technology has broadened its applications to many fields through continuous data updates and steady performance improvement, said the company’s chief executive Kim Dong-min during a recent interview with Maeil Business Newspaper. It takes only 10 to 30 seconds for the AI system to analyze the presence and severity of diseases such as stroke, prostate cancer, and lung disease, and pathological images, said Kim, adding large hospitals in Korea are already using the company’s technology to diagnose and treat patients. AIHub is advantageous in its simultaneous analysis of medical images and genomic information for various lung diseases and cancers. The Medical Genomics service is launched in many countries around the world, and sales already began to come from this service, Kim said. Another advantage of AIHub is that AI diagnosis can be easily performed even in areas with poor internet access, making it easier to be adopted in Southeast Asia, Latin America and the Middle East regions where cloud connectivity and employment is relatively low. Clinics can install the AIHub solution on a laptop with Intel CPU without the internet connection. By linking HandMed, a portable shooting and analyzing to the laptop, it is possible to diagnose diseases without an internet cloud server. Thanks to this, AIHub has been approved in more than 50 countries and territories worldwide. JLK is currently working on a 45-billion won ($38.2 million) state project together with Severance Hospital. The company recently signed a partnership agreement with Naver Cloud to develop broader application technologies. Kim who studied AI and brain science in Japan joined the company as Chief Technology Officer in 2016 and became CEO in 2019. By Kim Si-gyun and Minu Kim TUE

JLK Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

JLK Group Rank

  • When was JLK Group founded?

    JLK Group was founded in 2014.

  • Where is JLK Group's headquarters?

    JLK Group's headquarters is located at #302, Mirae YunghamGisul B/D, Cheongju-si.

  • What is JLK Group's latest funding round?

    JLK Group's latest funding round is IPO.

  • How much did JLK Group raise?

    JLK Group raised a total of $32.64M.

  • Who are the investors of JLK Group?

    Investors of JLK Group include KB Investment, DAOL Investment, Find Value Asset Management, InterVest, SL Investment and 4 more.

  • Who are JLK Group's competitors?

    Competitors of JLK Group include Lunit and 3 more.

  • What products does JLK Group offer?

    JLK Group's products include ATROSCAN and 4 more.

  • Who are JLK Group's customers?

    Customers of JLK Group include Hanshin Medipia, Seoul National University Hospital Healthcare System Gangnam Center , Doctor Net, CHAI (Clinton Health Access Initiatives) and Euijungbu Eulji University Hospital.

You May Also Like

Enlitic Logo
Enlitic

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Qure.ai Logo
Qure.ai

Qure.ai has developed an artificial intelligence-based system to identify abnormalities in head CT scans. The company aims to leverage deep learning effectively to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. It was founded in 2016 and is based in Mumbai, India.

S
Shukun Technology

Shukun Technology develops diagnostic systems by using machine learning and AI technology for hospitals to improve efficiency. The company focuses on cardiovascular diagnosis.

QUIBIM Logo
QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Perspectum Logo
Perspectum

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.

RapidAI Logo
RapidAI

RapidAI is using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.